ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $264,195 | -83.8% | 13,500 | -86.7% | 0.00% | -75.0% |
| Q3 2022 | $1,627,000 | +756.3% | 101,856 | +638.1% | 0.00% | – |
| Q2 2022 | $190,000 | -90.9% | 13,800 | -85.6% | 0.00% | -100.0% |
| Q4 2021 | $2,085,000 | +7.4% | 95,569 | +170.0% | 0.00% | -63.6% |
| Q4 2020 | $1,941,000 | +2105.7% | 35,390 | +812.8% | 0.01% | +1000.0% |
| Q4 2019 | $88,000 | +486.7% | 3,877 | +197.3% | 0.00% | – |
| Q3 2019 | $15,000 | -99.2% | 1,304 | -99.0% | 0.00% | -100.0% |
| Q2 2019 | $1,977,000 | -61.4% | 131,748 | -54.9% | 0.02% | -33.3% |
| Q1 2019 | $5,120,000 | – | 291,984 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |